DK104460C - Fremgangsmåde til fremstilling af 2-methyl-3-hydroxypyridiner eller syreadditionssalte deraf. - Google Patents

Fremgangsmåde til fremstilling af 2-methyl-3-hydroxypyridiner eller syreadditionssalte deraf.

Info

Publication number
DK104460C
DK104460C DK218162A DK218162A DK104460C DK 104460 C DK104460 C DK 104460C DK 218162 A DK218162 A DK 218162A DK 218162 A DK218162 A DK 218162A DK 104460 C DK104460 C DK 104460C
Authority
DK
Denmark
Prior art keywords
hydroxypyridines
methyl
preparation
acid addition
addition salts
Prior art date
Application number
DK218162A
Other languages
English (en)
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Application granted granted Critical
Publication of DK104460C publication Critical patent/DK104460C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79—Acids; Esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/65—One oxygen atom attached in position 3 or 5
    • C07D213/66—One oxygen atom attached in position 3 or 5 having in position 3 an oxygen atom and in each of the positions 4 and 5 a carbon atom bound to an oxygen, sulphur, or nitrogen atom, e.g. pyridoxal
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/65—One oxygen atom attached in position 3 or 5
    • C07D213/66—One oxygen atom attached in position 3 or 5 having in position 3 an oxygen atom and in each of the positions 4 and 5 a carbon atom bound to an oxygen, sulphur, or nitrogen atom, e.g. pyridoxal
    • C07D213/67—2-Methyl-3-hydroxy-4,5-bis(hydroxy-methyl)pyridine, i.e. pyridoxine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
DK218162A 1961-05-15 1962-05-14 Fremgangsmåde til fremstilling af 2-methyl-3-hydroxypyridiner eller syreadditionssalte deraf. DK104460C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10985361A 1961-05-15 1961-05-15
US16668862A 1962-01-16 1962-01-16

Publications (1)

Publication Number Publication Date
DK104460C true DK104460C (da) 1966-05-23

Family

ID=26807438

Family Applications (1)

Application Number Title Priority Date Filing Date
DK218162A DK104460C (da) 1961-05-15 1962-05-14 Fremgangsmåde til fremstilling af 2-methyl-3-hydroxypyridiner eller syreadditionssalte deraf.

Country Status (8)

Country Link
BE (1) BE617500A (da)
BR (1) BR6239058D0 (da)
CH (1) CH412889A (da)
DE (1) DE1470022C3 (da)
DK (1) DK104460C (da)
FR (1) FR1323941A (da)
GB (1) GB966805A (da)
SE (1) SE309236B (da)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3620873A (en) * 1969-03-26 1971-11-16 Ercon Inc Making metal-plastic gasket materials
EP1640005A3 (en) * 1999-03-08 2006-06-07 Medicure International Inc. Pyridoxal analogues for the treatment of disorders caused by a deficiency in vitamin B6
ES2250112T3 (es) 1999-03-08 2006-04-16 Medicure Inc. Analogos de piridoxal para el tratamiento de trastornos causados por carencia de vitamina b6.
CA2376029A1 (en) 1999-07-13 2001-01-18 Medicure Inc. Use of pyridoxin derivatives for the treatment of diabetes and related complications
US6677356B1 (en) 1999-08-24 2004-01-13 Medicure International Inc. Treatment of cardiovascular and related pathologies
AU3718501A (en) 2000-02-29 2001-09-12 Medicure Int Inc Cardioprotective phosphonates and malonates
JP2003528146A (ja) 2000-03-28 2003-09-24 メディキュア インターナショナル インコーポレイテッド 脳血管疾患の治療
US6897228B2 (en) 2000-07-07 2005-05-24 Medicure International Inc. Pyridoxine and pyridoxal analogues: new uses
AU2001272263B2 (en) 2000-07-07 2005-12-15 Medicure International Inc. Pyridoxine and pyridoxal analogues: cardiovascular therapeutics
US6548519B1 (en) 2001-07-06 2003-04-15 Medicure International Inc. Pyridoxine and pyridoxal analogues: novel uses

Also Published As

Publication number Publication date
DE1470022C3 (de) 1978-03-09
DE1470022A1 (de) 1969-01-16
DE1470022B2 (de) 1977-07-21
FR1323941A (fr) 1963-04-12
SE309236B (da) 1969-03-17
GB966805A (en) 1964-08-19
CH412889A (de) 1966-05-15
BR6239058D0 (pt) 1973-05-24
BE617500A (fr) 1962-11-12

Similar Documents

Publication Publication Date Title
DK107029C (da) Fremgangsmåde til fremstilling af substituerede 2-arylamino-1,3-diazacycloalkener eller syreadditionssalte deraf.
DK114903B (da) Fremgangsmåde til fremstilling af 9,10-dihydro-ergovalin eller syreadditionssalte heraf.
DK104460C (da) Fremgangsmåde til fremstilling af 2-methyl-3-hydroxypyridiner eller syreadditionssalte deraf.
DK114840B (da) Fremgangsmåde til fremstilling af diaralkylaminer eller syreadditionssalte heraf.
DK114559B (da) Fremgangsmåde til fremstilling af hydroxydiaminer eller syreadditionssalte deraf.
DK103079C (da) Fremgangsmåde til fremstilling af 4-amino-quinolinforbindelser eller syreadditionssalte deraf.
DK111894B (da) Fremgangsmåde til fremstilling af diphenylalkylaminer eller syreadditionssalte deraf.
DK105205C (da) Fremgangsmåde til fremstilling af pyridyl- eller pyrazyloxyalkylaminoalkylaminer eller syreadditionssalte heraf.
DK106495C (da) Fremgangsmåde til fremstilling af phenylalkylaminer eller syreadditionssalte deraf.
DK106147C (da) Fremgangsmåde til fremstilling af aminoquinolinforbindelser eller syreadditionssalte deraf.
DK103672C (da) Fremgangsmåde til fremstilling af phenylpropanolaminer eller syreadditionssalte heraf.
DK103941C (da) Fremgangsmåde til fremstilling af 3-thiocarbamoyl-phenthiazinforbindelser eller syreadditionssalte deraf.
DK103017C (da) Fremgangsmåde til fremstilling af basisk substituerede dibenzocycloheptadien- eller dibenzocycloheptatrienforbindelser eller syreadditionssalte deraf.
DK110091C (da) Fremgangsmåde til fremstilling af substituerede diphenylalkylaminer eller syreadditionssalte heraf.
DK102807C (da) Fremgangsmåde til fremstilling af substituerede diphenylalkenylaminer eller syreadditionssalte heraf.
DK118189B (da) Analogifremgangsmåde til fremstilling af benzyloxyaminer eller syreadditionssalte heraf.
DK102965C (da) Fremgangsmåde til fremstilling af 5-aryl-benzodiazepinforbindelser eller syreadditionssalte deraf.
DK129714B (da) Fremgangsmåde til fremstilling af benzimidazolinoner eller syreadditionssalte deraf.
DK96113C (da) Fremgangsmåde til fremstilling af o-benzylphenoxy-β-1-piperidinopropan eller syreadditionssalte deraf.
DK99268C (da) Fremgangsmåde til fremstilling af aminobenzoksacykloalkaner eller syreadditionssalte deraf.
DK101066C (da) Fremgangsmåde til fremstilling af dihalogenaminobenzylaminer eller syreadditionssalte heraf.
DK104988C (da) Fremgangsmåde til fremstilling af thenylguanidiner eller syreadditionssalte heraf.
DK102575C (da) Fremgangsmåde til fremstilling af N-benzodioxylurethaner eller syreadditionssalte heraf.
DK102517C (da) Fremgangsmåde til fremstilling af dihydrodibenzocyclohetener eller syreadditionssalte heraf.
DK101795C (da) Fremgangsmåde til fermstilling af dihalogenaminobenzylaminer eller syreadditionssalte heraf.